 Standard of care laboratory tests will be performed by the clinical laboratory at Mount Sinai Hospital. All other measurements will be completed at Prometheus Therapeutics Diagnostics in San Diego, California or at a Takeda identified lab for vedolizumab concentrations and antibodies. 